These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36270332)

  • 41. Nucleoprotein-based ELISA for detection of SARS-COV-2 IgG antibodies: Could an old assay be suitable for serodiagnosis of the new coronavirus?
    Tozetto-Mendoza TR; Kanunfre KA; Vilas-Boas LS; Sanchez Espinoza EP; Paião HGO; Rocha MC; de Paula AV; de Oliveira MS; Zampelli DB; Vieira JM; Buss L; Costa SF; Sabino EC; Witkin SS; Okay TS; Mendes-Correa MC
    J Virol Methods; 2021 Apr; 290():114064. PubMed ID: 33453299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay.
    Mariën J; Ceulemans A; Michiels J; Heyndrickx L; Kerkhof K; Foque N; Widdowson MA; Mortgat L; Duysburgh E; Desombere I; Jansens H; Van Esbroeck M; Ariën KK
    J Virol Methods; 2021 Feb; 288():114025. PubMed ID: 33227340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid, label-free, and sensitive point-of-care testing of anti-SARS-CoV-2 IgM/IgG using all-fiber Fresnel reflection microfluidic biosensor.
    Xu W; Liu J; Song D; Li C; Zhu A; Long F
    Mikrochim Acta; 2021 Jul; 188(8):261. PubMed ID: 34278534
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance of the FREND™ COVID-19 IgG/IgM Duo point-of-care test for SARS-CoV-2 antibody detection.
    De Munck DG; Peeters B; Huyghe E; Goossens H; Ieven M; Matheeussen V
    Acta Clin Belg; 2022 Jun; 77(3):647-652. PubMed ID: 34152943
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott).
    Charpentier C; Ichou H; Damond F; Bouvet E; Chaix ML; Ferré V; Delaugerre C; Mahjoub N; Larrouy L; Le Hingrat Q; Visseaux B; Mackiewicz V; Descamps D; Fidouh-Houhou N
    J Clin Virol; 2020 Nov; 132():104618. PubMed ID: 32919222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the automated LIAISON
    Bonelli F; Blocki FA; Bunnell T; Chu E; De La O A; Grenache DG; Marzucchi G; Montomoli E; Okoye L; Pallavicini L; Streva VA; Torelli A; Wagner A; Zanin D; Zierold C; Wassenberg JJ
    Clin Chem Lab Med; 2021 Jul; 59(8):1463-1467. PubMed ID: 33711225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bovine Serum Albumin-Protected Gold Nanoclusters for Sensing of SARS-CoV-2 Antibodies and Virus.
    Shen Q; Hossain F; Fang C; Shu T; Zhang X; Law JLM; Logan M; Houghton M; Tyrrell DL; Joyce MA; Serpe MJ
    ACS Appl Mater Interfaces; 2023 Jun; 15(25):29914-29926. PubMed ID: 37314985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
    Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients' Management.
    Speletas M; Kyritsi MA; Vontas A; Theodoridou A; Chrysanthidis T; Hatzianastasiou S; Petinaki E; Hadjichristodoulou C
    Front Immunol; 2020; 11():609242. PubMed ID: 33424863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Development and application of triple antibodies-based sandwich ELISA for detecting nucleocapsid protein of SARS-associated coronavirus].
    Qiu LW; Tang HW; Wang YD; Liao JE; Hao W; Wen K; He XM; Che XY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Apr; 26(4):277-81. PubMed ID: 15941537
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microfluidic Immunoassays for Sensitive and Simultaneous Detection of IgG/IgM/Antigen of SARS-CoV-2 within 15 min.
    Lin Q; Wen D; Wu J; Liu L; Wu W; Fang X; Kong J
    Anal Chem; 2020 Jul; 92(14):9454-9458. PubMed ID: 32615038
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of Recombinant Immunoglobulin G-Binding Luciferase-Based Signal Amplifiers in Immunoassays.
    Eom S; Bae Y; Kim S; Choi H; Park J; Kang S
    Anal Chem; 2020 Apr; 92(7):5473-5481. PubMed ID: 32142265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Usefulness of ELISA Using Total Antibody against Plant-Expressed Recombinant Nucleocapsid Protein of SARS-CoV-2.
    Tariq M; Hur J; Seo JW; Kim DY; Yun NR; Lee YM; Bang MS; Hwang SY; Kim CM; Lee JH; Song KH; Lee H; Jung J; Park JY; Kim HB; Kim ES; Lee S; Kim DM
    Microbiol Spectr; 2021 Dec; 9(3):e0067221. PubMed ID: 34817278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Highly Sensitive and Specific Multiplex Antibody Assays To Quantify Immunoglobulins M, A, and G against SARS-CoV-2 Antigens.
    Dobaño C; Vidal M; Santano R; Jiménez A; Chi J; Barrios D; Ruiz-Olalla G; Rodrigo Melero N; Carolis C; Parras D; Serra P; Martínez de Aguirre P; Carmona-Torre F; Reina G; Santamaria P; Mayor A; García-Basteiro AL; Izquierdo L; Aguilar R; Moncunill G
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33127841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simultaneous Detection of SARS-CoV-2 IgG/IgM Antibodies, Using Gold Nanoparticles-Based Lateral Flow Immunoassay.
    Ahmadi A; Mirzaeizadeh Z; Omidfar K
    Monoclon Antib Immunodiagn Immunother; 2021 Oct; 40(5):210-218. PubMed ID: 34678096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of a lateral flow immunoassay strip for rapid detection of IgG antibody against SARS-CoV-2 virus.
    Wen T; Huang C; Shi FJ; Zeng XY; Lu T; Ding SN; Jiao YJ
    Analyst; 2020 Aug; 145(15):5345-5352. PubMed ID: 32568341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies.
    Mairesse A; Favresse J; Eucher C; Elsen M; Tré-Hardy M; Haventith C; Gruson D; Dogné JM; Douxfils J; Göbbels P
    Clin Biochem; 2020 Dec; 86():23-27. PubMed ID: 32858061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic Potential of a Luminex-Based Coronavirus Disease 2019 Suspension Immunoassay (COVID-19 SIA) for the Detection of Antibodies against SARS-CoV-2.
    Hoffman T; Kolstad L; Lindahl JF; Albinsson B; Bergqvist A; Rönnberg B; Lundkvist Å
    Viruses; 2021 May; 13(6):. PubMed ID: 34073484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapid Quantitative Point-Of-Care Diagnostic Test for Post COVID-19 Vaccination Antibody Monitoring.
    Moeller ME; Engsig FN; Bade M; Fock J; Pah P; Soerensen AL; Bang D; Donolato M; Benfield T
    Microbiol Spectr; 2022 Apr; 10(2):e0039622. PubMed ID: 35357223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.